The immunogenicity of the determinants, and the extent of spreading of IL-4 responses to other ß-cell autoantigens, correlated with the efficacy of ASIs to inhibit subsequent T1D development [9]. The gene discussed is IL4; the disease is type 1 diabetes mellitus.